Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1

被引:8
|
作者
Lin, Yu [1 ]
Bai, Xia [2 ]
Zhou, Weina [2 ]
He, Yulin [2 ]
Wu, Yiwei [3 ]
Wang, Xiangcheng [2 ]
机构
[1] Inner Mongolia Med Univ, Dept Ontol Radiotherapy, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China
[2] Inner Mongolia Med Univ, Dept Nucl Med, Affiliated Hosp, Hohhot 010050, Inner Mongolia, Peoples R China
[3] Soochow Univ, Affiliated Hosp 1, Dept Nucl Med, Suzhou 215000, Jiangsu, Peoples R China
关键词
Radiation; TNBC; ZEB1; ATM; Migration; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; CELLS; CARCINOMA; RADIOTHERAPY; EXPRESSION; STRATEGIES; INVASION; PATHWAY; EMT;
D O I
10.1016/j.biopha.2018.08.026
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist. Knockdown of ZEB1 attenuated radiation induced cell migration and invasion, suggesting that ZEB1 is essential for radiation induced progression of TNBC. Radiation increased the protein stability of ZEB1, while had no effect on its mRNA expression. Particularly, the upregulation of ATM, which can phosphorylate and stabilize ZEB1, was involved in radiation induced upregulation of ZEB1. Collectively, we found that radiation can promote the migration, invasion and EMT of TNBC cells through stabilization of ZEB1 via ATM signals.
引用
收藏
页码:1624 / 1630
页数:7
相关论文
共 50 条
  • [21] DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1
    Hye-Youn Kim
    Young-Mi Kim
    Suntaek Hong
    Cell Death & Disease, 12
  • [22] Sulindac and triple negative breast cancer progression
    Xi, Y.
    Yi, B.
    Riker, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [23] AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
    Tian, Wenwen
    Tang, Yuhui
    Luo, Yongzhou
    Xie, Jindong
    Zheng, Shaoquan
    Zou, Yutian
    Huang, Xiaojia
    Wu, Linyu
    Zhang, Junsheng
    Sun, Yuying
    Tang, Hailin
    Du, Wei
    Li, Xing
    Xie, Xiaoming
    CELL DEATH & DISEASE, 2023, 14 (12)
  • [24] AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
    Wenwen Tian
    Yuhui Tang
    Yongzhou Luo
    Jindong Xie
    Shaoquan Zheng
    Yutian Zou
    Xiaojia Huang
    Linyu Wu
    Junsheng Zhang
    Yuying Sun
    Hailin Tang
    Wei Du
    Xing Li
    Xiaoming Xie
    Cell Death & Disease, 14
  • [25] Cancer cell-derived adrenomedullin downregulates Zeb1 in adipocytes to induce adipolysis and promote breast cancer progression
    Cao, Lixia
    Chen, Xiao
    Shi, Yi
    Yang, Shuang
    CANCER RESEARCH, 2024, 84 (06)
  • [26] ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
    Zhang, Xiang
    Zhang, Zhen
    Zhang, Qing
    Zhang, Quansheng
    Sun, Peiqing
    Xiang, Rong
    Ren, Guosheng
    Yang, Shuang
    CELL DEATH & DISEASE, 2018, 9
  • [27] ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer
    Liu, Lingjia
    Tong, Qi
    Liu, Shuo
    Cui, Jianlin
    Zhang, Quansheng
    Sun, Wei
    Yang, Shuang
    PLOS ONE, 2016, 11 (02):
  • [28] ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
    Xiang Zhang
    Zhen Zhang
    Qing Zhang
    Quansheng Zhang
    Peiqing Sun
    Rong Xiang
    Guosheng Ren
    Shuang Yang
    Cell Death & Disease, 9
  • [29] The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
    Chen, Anna
    Wong, Christina S. F.
    Liu, Mira C. P.
    House, Colin M.
    Sceneay, Jaclyn
    Bowtell, David D.
    Thompson, Erik W.
    Moeller, Andreas
    ONCOTARGET, 2015, 6 (02) : 862 - 873
  • [30] Association of ZEB1 and Vimentin with poor prognosis in metaplastic breast cancer
    Zawati, Imen
    Jlassi, Aida
    Adouni, Olfa
    Nouira, Meriem
    Manai, Maroua
    Rahal, Khaled
    Driss, Maha
    Manai, Mohamed
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 59